These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Postprandial peptide YY release is mediated by cholecystokinin. McFadden DW, Rudnicki M, Kuvshinoff B, Fischer JE. Surg Gynecol Obstet; 1992 Aug 15; 175(2):145-50. PubMed ID: 1636140 [Abstract] [Full Text] [Related]
7. The release of pancreatic polypeptide by intraduodenal l-phenylalanine in the dog. Beglinger C, Haecki W, Gyr K, Stalder GA. Hepatogastroenterology; 1981 Apr 15; 28(2):116-7. PubMed ID: 7216145 [Abstract] [Full Text] [Related]
8. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs. Kim CK, Lee KY, Wang T, Sun G, Chang TM, Chey WY. Am J Physiol; 1989 Dec 15; 257(6 Pt 1):G944-9. PubMed ID: 2481981 [Abstract] [Full Text] [Related]
9. Effect of pancreatic denervation and atropine on the pancreatic response to secretin. Kuvshinoff BW, Demar AR, James L, McFadden DW, Fink AS. Pancreas; 1993 Sep 15; 8(5):609-14. PubMed ID: 8302798 [Abstract] [Full Text] [Related]
10. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs. Konturek SJ, Tasler J, Konturek JW, Cieszkowski M, Szewczyk K, Hładij M, Anderson PS. Gut; 1989 Jan 15; 30(1):110-7. PubMed ID: 2920915 [Abstract] [Full Text] [Related]
11. Contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation in canine pancreas. Importance in pancreas transplantation. van der Burg MP, Gooszen HG, Guicherit OR, Jansen JB, Frölich M, van Haastert FA, Lamers CB. Diabetes; 1989 Sep 15; 38(9):1082-9. PubMed ID: 2670640 [Abstract] [Full Text] [Related]
12. Pancreatic protein secretion and gastrointestinal hormone release in response to parenteral amino acids and lipid in dogs. Fried GM, Ogden WD, Rhea A, Greeley G, Thompson JC. Surgery; 1982 Nov 15; 92(5):902-5. PubMed ID: 6813982 [Abstract] [Full Text] [Related]
13. Action of pancreatic polypeptide on exocrine pancreas and on release of cholecystokinin and secretin. Lonovics J, Guzman S, Devitt PG, Hejtmancik KE, Suddith RL, Rayford PL, Thompson JC. Endocrinology; 1981 May 15; 108(5):1925-30. PubMed ID: 7215307 [Abstract] [Full Text] [Related]
14. Somatostatin inhibits cholecystokinin-induced pancreatic protein secretion via cholinergic pathways. Brodish RJ, Kuvshinoff BW, McFadden DW, Fink AS. Pancreas; 1995 May 15; 10(4):401-6. PubMed ID: 7792297 [Abstract] [Full Text] [Related]
15. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RS, Clineschmidt BV. J Pharmacol Exp Ther; 1987 Apr 15; 241(1):103-9. PubMed ID: 2437282 [Abstract] [Full Text] [Related]
16. Vagal, cholinergic regulation of pancreatic polypeptide secretion. Schwartz TW, Holst JJ, Fahrenkrug J, Jensen SL, Nielsen OV, Rehfeld JF, de Muckadell OB, Stadil F. J Clin Invest; 1978 Mar 15; 61(3):781-9. PubMed ID: 641155 [Abstract] [Full Text] [Related]